Fortitude Advisory Group L.L.C. I Bio, Inc. Transaction History

Fortitude Advisory Group L.L.C.

  • $166 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$0.23 - $0.46 $230 - $460
-1,000 Closed
0 $0
Q4 2021

May 20, 2022
BUY
$0.55 - $1.04 $550 - $1,040
1,000 New
1,000 $1,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Fortitude Advisory Group L.L.C. Portfolio

Follow Fortitude Advisory Group L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email